COMMUNIQUÉS West-GlobeNewswire

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
04/05/2026
MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis symptoms in 20 mg and 40 mg TID doses vs placebo Improvements observed across key symptoms, including nausea, early satiety, [...]
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
04/05/2026
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies [...]
CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting
04/05/2026
Oral presentation includes early readouts from preclinical testing of CAR-encoding episomal DNA delivered by targeted lipid nanoparticles CPTx will present two posters at ASGCT 2026 Munich, Germany — May 4, 2026 — CPTx [...]
Artios Further Expands Leadership Team to Advance Oncology Pipeline and Accelerate Regulatory Execution
04/05/2026
Jeremy B. Fitch, MBA, appointed as Chief Business Officer Michael A. Alrutz, J.D., Ph.D., appointed as General Counsel Guy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United Kingdom and NEW YORK, [...]
Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026
04/05/2026
COPENHAGEN, Denmark, May 4, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will provide a business update and [...]
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
04/05/2026
• MacroGenics receives $60 million cash payment from Sagard Healthcare Partners (Sagard), with the potential to receive an additional near-term sales-based milestone of up to $20 million ROCKVILLE, MD, May 04, 2026 ( [...]
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
04/05/2026
PALO ALTO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/05/2026
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]
Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas
04/05/2026
Clinically significant angiokeratomas represent a rare, chronic and debilitating lymphatic malformation with no FDA-approved therapies and an estimated more than 50,000 diagnosed patients in the U.S. Phase 2 single-arm [...]
Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
04/05/2026
Six-month data from adult Cohort 4 show structural and functional improvements and a favorable safety profile; early safety data from pediatric Cohort 5 are consistent with adult cohorts Enrollment underway in pivotal [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
04/05/2026
COPENHAGEN, Denmark, May 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on March 12, 2026, under which the Company will repurchase shares for an amount up to [...]
Mother’s Day Gifting Is Changing: From Symbolic Presents to Meaningful Relief — Bob and Brad Marks the Occasion with Up to 30% Off Wellness Devices
04/05/2026
WINONA, Minn., May 04, 2026 (GLOBE NEWSWIRE) -- Mother’s Day gifting is undergoing a subtle shift, with more consumers moving beyond traditional symbolic presents toward products that offer practical, everyday relief. [...]
Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
04/05/2026
Successful partnership continues as bispecific antibody candidate moves to GMP manufacturing; project highlights Japan's advanced capabilities in bioprocessing and AGC Biologics' expanding global network CHIBA, Japan, [...]
Halo Care Skin Tag Remover Claims Evaluated: The Strongest, Most Effective Mole & Skin Tag Corrector Serum
02/05/2026
Halo Care Skin Tag Remover Sanguinaria Canadensis and Zincum Muriaticum Formula Explained: 2026 Pricing, Refund, and Dermatologist Guidance New York, NY, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support
02/05/2026
VisioCore Vision Support Supplement Ingredients, Lutein and Zeaxanthin Formula, Pricing, Official Website Access, and 60-Day Guarantee Explained for 2026 Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements [...]
MemoPryl Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk
02/05/2026
MemoPryl Scam Searches, Complaints, and Side Effects Risk Explained for Adults Comparing Nootropic Memory Supplements in 2026 Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the [...]
Milken Institute Global Conference 2026 Set to Open Tomorrow in Beverly Hills with KFSH Participation
02/05/2026
BEVERLY HILLS, Calif., May 02, 2026 (GLOBE NEWSWIRE) -- The Milken Institute Global Conference 2026 is set to open tomorrow in Beverly Hills, bringing together a global cross section of leaders from healthcare, finance [...]
Avicanna Announces Change in Board of Directors
02/05/2026
TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation [...]
Gala GLP-1 Weight Loss Claims Evaluated: The Most Trusted GLP1 Tirzepetide Telehealth Prescription Treatment & Tracker Provider
01/05/2026
How Gala GLP-1's Compounded Tirzepatide and Semaglutide Telehealth Plans Work: Licensed Providers, $179/Mo Pricing, No Insurance Required, and Access in All 50 States in 2026 Wilmington, Delaware, May 01, 2026 (GLOBE [...]

Pages